Yes-Associated Protein 1 Inhibition Induces Immunogenic Cell Death and Synergizes with Radiation and PD-1 Blockade (vol 116, pg 894, 2023)

被引：0

作者：

Zhuang, Yuan ^{[1
]}

Wang, Yuzi ^{[1
,2
]}

Liu, Chang ^{[1
]}

Li, Sihan ^{[1
]}

Du, Shuyan ^{[3
]}

Li, Guang ^{[1
]}

机构：

[1] China Med Univ, Hosp 1, Dept Radiat Oncol, Shenyang, Peoples R China

[2] Univ Tsukuba, Proton Med Res Ctr, Tsukuba, Japan

[3] China Med Univ, Hosp 1, Dept Cent Lab, Shenyang, Peoples R China

来源：

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2024年 / 119卷 / 03期

关键词：

D O I：

10.1016/j.ijrobp.2024.02.058

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1032 / 1033

页数：2

共 50 条

[21] Fibroblast activation protein targeted radiotherapy induces an immunogenic tumor microenvironment and enhances the efficacy of PD-1 immune checkpoint inhibition
Zboralski, Dirk
Osterkamp, Frank
Christensen, Esben
Bredenbeck, Anne
Schumann, Anne
Hoehne, Aileen
Schneider, Eberhard
Paschke, Matthias
Ungewiss, Jan
Haase, Christian
Robillard, Liliane
Simmons, Andrew D.
Harding, Thomas C.
Nguyen, Minh
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (09) : 2621 - 2635
[22] Combination of protein phosphatase 2A inhibition and PD-1 blockade synergistically induces regression of murine intracranial glioblastoma
Maggio, Dominic
Ho, Winson
Breese, Rebecca
Lu, Rongze
Wang, Herui
Heiss, John
Gilbert, Mark
Zhuang, Zhengping
JOURNAL OF NEUROSURGERY, 2018, 128 (04) : 8 - 8
[23] A Comparison of Outcomes in Recurrent High Grade Gliomas Treated With Hypofractionated Stereotactic Radiation Therapy With or Without Programmed Cell Death Protein 1 (PD-1) Blockade
Grass, G. D.
Sahebjam, S.
Macaulay, R. J.
Forsyth, P.
Tran, N.
Etame, A. B.
Arrington, J.
Sarangkasiri, S.
Johnstone, P. A. S.
Robinson, T. J.
Yu, H. H. M.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : S102 - S102
[24] Targeting IL-1B synergizes with PD-1 blockade for enhanced T and B cell immune responses and inhibition of early lung cancer development
Treekitkarnmongkol, Warapen
Han, Guangchun
Rahal, Zahraa
Feng, Jiping
Sinjab, Ansam
Cascone, Tina
Stevenson, Christopher S.
Sweeney, Cheryl
Edwards, Matt
Spira, Avrum
Fujimoto, Junya
Moghaddam, Seyed Javad
Wang, Linghua
Kadara, Humam
CANCER RESEARCH, 2023, 83 (07)
[25] Neurological Complications Associated With Anti-Programmed Death 1 (PD-1) Antibodies (vol 74, pg 1216, 2017)
Kao, J. C.
Liao, B.
Markovic, S. N.
JAMA NEUROLOGY, 2017, 74 (10) : 1271 - 1271
[26] LSD1 inhibition sustains T cell invigoration with a durable response to PD-1 blockade (vol 12, 6831, 2021)
Liu, Yi
Debo, Brian
Li, Mingfeng
Shi, Zhennan
Sheng, Wanqiang
Shi, Yang
NATURE COMMUNICATIONS, 2022, 13 (01)
[27] Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma (vol 12, pg 1, 2020)
Ran, X.
Xiao, J.
Zhang, Y.
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2022, 14
[28] Oncolytic virus-mediated p53 overexpression promotes immunogenic cell death and efficacy of PD-1 blockade in pancreatic cancer
Araki, Hiroyuki
Tazawa, Hiroshi
Kanaya, Nobuhiko
Kajiwara, Yoshinori
Yamada, Motohiko
Hashimoto, Masashi
Kikuchi, Satoru
Kuroda, Shinji
Yoshida, Ryuichi
Umeda, Yuzo
Urata, Yasuo
Kagawa, Shunsuke
Fujiwara, Toshiyoshi
MOLECULAR THERAPY-ONCOLYTICS, 2022, 27 : 3 - 13
[29] CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner
Zhang, Qian-Feng
Li, Jia
Jiang, Kuo
Wang, Rui
Ge, Jun-li
Yang, Hong
Liu, Shu-Juan
Jia, Lin-Tao
Wang, Lei
Chen, Bi-Liang
THERANOSTICS, 2020, 10 (23): : 10619 - 10633
[30] RAS-association domain family 1A regulates the abnormal cell proliferation in psoriasis via inhibition of Yes-associated protein
Jia, Jinjing
Wang, Ning
Zheng, Yan
Mo, Xiumei
Zhang, Yu
Ye, Siqi
Liu, Junfeng
Yan, Fenggen
Li, Hongyi
Chen, Dacan
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2021, 25 (11) : 5070 - 5081

← 1 2 3 4 5 →